Agios Pharmaceuticals
Public company. Publicly listed (AGIO); its private filings are not venture rounds.
What matters now
- 1 investornamed
1 investor on record.
The investors already on the cap table shape who leads the next round.
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 2
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
- Nov 16, 2011Form D equity offering · $78.0M (form d sold)Arch Venture Partners via Robert Taylor NelsenFact Form D · “Agios Pharmaceuticals Inc Form D, first filed 2011-11-22”
- Apr 14, 2010Form D equity offering · $8.8M (form d sold)Arch Venture Partners via Robert Taylor NelsenFact Form D · “Agios Pharmaceuticals Inc Form D, first filed 2010-04-26”
- Arch Venture Partners portfolio listing Fact archventure.com
- Arch Venture Partners form d related, Robert Taylor Nelsen (strongly supported) Inference sec.gov
- Arch Venture Partners form d related, Robert Taylor Nelsen (strongly supported) Inference sec.gov
Every observation on this company
- Listed on portfolio page: Arch Venture Partners Sep 30, 2026 Fact Firm website
- Listed on portfolio page: Arch Venture Partners Sep 16, 2026 Fact Firm website
- Listed on portfolio page: Arch Venture Partners Sep 14, 2026 Fact Firm website